Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Virus-like Particles Market – By Product Type

1.3.2        North America Virus-like Particles Market – By Source

1.3.3        North America Virus-like Particles Market – By Application

1.3.4        North America Virus-like Particles Market – By Country

2.           North America Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           North America Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Infectious Viral Diseases

5.1.2        The Elevating Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Presence of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Raising Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Constant Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           North America Virus-like Particles Market Analysis

6.1         North America Virus-like Particles Market Revenue Forecast and Analysis

7.           North America Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         North America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           North America Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         North America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         North America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       US: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.1.4       US: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)

10.1.1.1.5       US: Virus-like Particles Market, by Application, 2019–2028 (US$ Million)

10.1.1.2       Canada: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Canada: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.2.4       Canada: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)

10.1.1.2.5       Canada Virus-Like Particles Market, by Application, 2019–2028 (US$ Million)

10.1.1.3       Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Mexico: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.3.4       Mexico: Virus-like Particles Market, by Source, 2019–2028 (US$ Million)

10.1.1.3.5       Mexico: Virus-like Particles Market, by Application, 2019–2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on North America Virus-like Particles Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        North America Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Dynavax Technologies

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sanofi

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Serum Institute of India Pvt. Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BHARAT BIOTECH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      LG Chem

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      VBI Vaccines Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)

Table 5.             Canada: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Virus-Like Particles Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Million)

Table 11.          Organic Developments Done by Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1.           North America Virus-like particles Market Segmentation

Figure 2.           North America Virus-like particles Market Segmentation, By Country

Figure 3.           North America Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in North America Virus-like particles Market

Figure 5.           The US to Show Significant Growth during Forecast Period

Figure 6.           North America Virus-like Particles Market, Industry Landscape

Figure 7.           North America PEST Analysis

Figure 8.           North America Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           North America Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        North America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        North America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        North America: Virus-like Particles Market, by Key Country – Revenue (2021) (US$ Million)

Figure 23.        North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)

Figure 24.        US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Impact of COVID-19 Pandemic in North American Country Markets